{"transactions":[{"id":700512,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-07-31T00:31:52.000Z","date":"2026-07-28","kind":"exercise","planned":false,"acquired":false,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These RSUs reported in Table II were granted to the Reporting Person on July 28, 2025 as part of an aggregate award of 140,000 RSUs and initially reported in Table I of the Form 4 filed on July 30, 2025, because they were solely settleable in shares at the time of grant. These RSUs are being moved to Table II as of this Form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's Ordinary Shares upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs reported in Table II are fully vested as of July 28, 2026 (the one-year anniversary of the grant date). The remainder of the 140,000 RSUs reported in Table I (56,000 RSUs) are subject to vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs reported in Table II are fully vested as of July 28, 2026 (the one-year anniversary of the grant date). The remainder of the 140,000 RSUs reported in Table I (56,000 RSUs) are subject to vesting."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0000905148-26-003412","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514826003412/form4.xml","form_type":"4"}},{"id":700511,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2026-07-31T00:31:52.000Z","date":"2026-07-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":84000,"price":8.56,"value":719040.0,"ownership":{"direct":true},"balance_after":68793,"source":{"system":"sec-edgar","filing":"0000905148-26-003412","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514826003412/form4.xml","form_type":"4"}},{"id":700510,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2026-07-31T00:31:52.000Z","date":"2026-07-28","kind":"exercise","planned":false,"acquired":true,"shares":84000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's Ordinary Shares upon vesting."}],"balance_after":152793,"source":{"system":"sec-edgar","filing":"0000905148-26-003412","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514826003412/form4.xml","form_type":"4"}},{"id":857948,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:49:58.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":520000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 3, 2027, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":520000,"derivative":{"exercise_price":9.36,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":520000},"source":{"system":"sec-edgar","filing":"0000905148-26-001176","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514826001176/form4.xml","form_type":"4"}},{"id":1078958,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2025-07-30T21:50:50.000Z","date":"2025-07-28","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":152793,"source":{"system":"sec-edgar","filing":"0000905148-25-002656","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514825002656/form4.xml","form_type":"4"}},{"id":1216897,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-07T21:30:55.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 5, 2026, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":375000,"derivative":{"exercise_price":14.95,"expiration_date":"2035-03-05","underlying":"Ordinary Shares","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0000905148-25-000884","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514825000884/form4.xml","form_type":"4"}},{"id":1609483,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-01T02:03:58.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":307000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2025, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":307000,"derivative":{"exercise_price":30.3,"expiration_date":"2034-02-27","underlying":"Ordinary Shares","underlying_shares":307000},"source":{"system":"sec-edgar","filing":"0000905148-24-000836","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514824000836/form4.xml","form_type":"4"}},{"id":1888419,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-18T01:54:31.000Z","date":"2023-05-17","kind":"exercise","planned":true,"acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares subject to the option have fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The Reporting Person holds options that give him the right to acquire an aggregate of 2,114,700 shares at exercise prices ranging from $12.15 to $52.97, of which 1,626,365 are currently exercisable, and 488,335 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award."}],"balance_after":0,"derivative":{"exercise_price":29.81,"expiration_date":"2024-02-04","underlying":"Ordinary Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001140361-23-025344","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123025344/form4.xml","form_type":"4"}},{"id":1888418,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-05-18T01:54:31.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":14934,"price":74.4945,"value":1112500.863,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $74.06 to $74.99, inclusive."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001140361-23-025344","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123025344/form4.xml","form_type":"4"}},{"id":1888417,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-05-18T01:54:31.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":19864,"price":73.604,"value":1462069.856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $73.06 to $74.05, inclusive."}],"balance_after":27727,"source":{"system":"sec-edgar","filing":"0001140361-23-025344","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123025344/form4.xml","form_type":"4"}},{"id":1888416,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-05-18T01:54:31.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":10202,"price":72.7035,"value":741721.107,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $72.06 to $73.055, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4."}],"balance_after":47591,"source":{"system":"sec-edgar","filing":"0001140361-23-025344","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123025344/form4.xml","form_type":"4"}},{"id":1888415,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-05-18T01:54:31.000Z","date":"2023-05-17","kind":"exercise","planned":true,"acquired":true,"shares":45000,"price":29.81,"value":1341450.0,"ownership":{"direct":true},"balance_after":57793,"source":{"system":"sec-edgar","filing":"0001140361-23-025344","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123025344/form4.xml","form_type":"4"}},{"id":1971821,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-04T02:30:32.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person holds options that give him the right to acquire an aggregate of 2,159,700 shares at exercise prices ranging from $12.15 to $52.97, of which 1,642,200 are currently exercisable, and 517,500 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award."}],"balance_after":155000,"derivative":{"exercise_price":52.97,"expiration_date":"2033-03-02","underlying":"Ordinary Shares","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001140361-23-010181","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036123010181/form4.xml","form_type":"4"}},{"id":2148557,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"exercise","acquired":false,"shares":16412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F10","text":"The Reporting Person holds options that give him the right to acquire an aggregate of 2,004,700 shares at exercise prices ranging from $12.15 to $32.45, of which 1,507,303 are currently exercisable, and 497,397 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award."}],"balance_after":0,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":16412},"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148556,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":129,"price":58.93,"value":7601.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148555,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":243,"price":57.7031,"value":14021.8533,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transaction was executed in multiple trades in prices ranging from $57.37 to $58.08, inclusive."}],"balance_after":12922,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148554,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":40,"price":56.1915,"value":2247.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades in prices ranging from $56.115 to $56.34, inclusive."}],"balance_after":13165,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148553,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":1342,"price":55.3236,"value":74244.2712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $54.995 to $55.94, inclusive."}],"balance_after":13205,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148552,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":4748,"price":54.376,"value":258177.248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $53.96 to $54.91, inclusive."}],"balance_after":14547,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148551,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":5852,"price":53.3966,"value":312476.9032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $52.96 to $53.92, inclusive."}],"balance_after":19295,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148550,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":2333,"price":52.4397,"value":122341.8201,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $51.95 to $52.93, inclusive."}],"balance_after":25147,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148549,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":552,"price":51.2999,"value":28317.5448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $50.84 to $51.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 8 of this Form 4."}],"balance_after":27480,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148548,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":128,"price":49.41,"value":6324.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":28032,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148547,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":1045,"price":48.09,"value":50254.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":28160,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2148546,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:08.000Z","date":"2022-09-28","kind":"exercise","acquired":true,"shares":16412,"price":6.41,"value":105200.92,"ownership":{"direct":true},"balance_after":29205,"source":{"system":"sec-edgar","filing":"0001140361-22-035564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122035564/form4.xml","form_type":"4"}},{"id":2151769,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-24T01:30:49.000Z","date":"2022-09-21","kind":"exercise","acquired":false,"shares":2720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person holds options that give him the right to acquire an aggregate of 2,021,112 shares at exercise prices ranging from $6.41 to $32.45, of which 1,509,237 are currently exercisable, and 511,875 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award."}],"balance_after":16412,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":2720},"source":{"system":"sec-edgar","filing":"0001140361-22-034588","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122034588/form4.xml","form_type":"4"}},{"id":2151768,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-09-24T01:30:49.000Z","date":"2022-09-21","kind":"sale","acquired":false,"shares":2720,"price":32.0183,"value":87089.776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $32.00 to $32.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001140361-22-034588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122034588/form4.xml","form_type":"4"}},{"id":2151767,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-09-24T01:30:49.000Z","date":"2022-09-21","kind":"exercise","acquired":true,"shares":2720,"price":6.41,"value":17435.2,"ownership":{"direct":true},"balance_after":15513,"source":{"system":"sec-edgar","filing":"0001140361-22-034588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122034588/form4.xml","form_type":"4"}},{"id":2177964,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-20T01:30:18.000Z","date":"2022-08-17","kind":"exercise","acquired":false,"shares":2181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person holds options that give him the right to acquire an aggregate of 2,023,832 shares at exercise prices ranging from $6.41 to $32.45, of which 1,497,476 are currently exercisable, and 526,356 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award."}],"balance_after":19132,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":2181},"source":{"system":"sec-edgar","filing":"0001567619-22-016512","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922016512/doc1.xml","form_type":"4"}},{"id":2177963,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-20T01:30:18.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":2181,"price":32.0287,"value":69854.5947,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $32.00 to $32.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001567619-22-016512","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922016512/doc1.xml","form_type":"4"}},{"id":2177962,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-20T01:30:18.000Z","date":"2022-08-17","kind":"exercise","acquired":true,"shares":2181,"price":6.41,"value":13980.21,"ownership":{"direct":true},"balance_after":14974,"source":{"system":"sec-edgar","filing":"0001567619-22-016512","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922016512/doc1.xml","form_type":"4"}},{"id":2186600,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-12","kind":"exercise","acquired":false,"shares":20284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The Reporting Person holds options that give him the right to acquire an aggregate of 2,026,013 shares at exercises prices ranging from $6.41 to $32.45, of which 1,499,657 are currently exercisable, and 526,356 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award."}],"balance_after":21313,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":20284},"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2186599,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-11","kind":"exercise","acquired":false,"shares":13650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":41597,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":13650},"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2186598,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-10","kind":"exercise","acquired":false,"shares":991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":55247,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":991},"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2186597,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":20284,"price":32.1579,"value":652290.8436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $32.00 to $32.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2186596,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-12","kind":"exercise","acquired":true,"shares":20284,"price":6.41,"value":130020.44,"ownership":{"direct":true},"balance_after":33077,"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2186595,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":13650,"price":32.1561,"value":438930.765,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $32.00 to $32.325, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2186594,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-11","kind":"exercise","acquired":true,"shares":13650,"price":6.41,"value":87496.5,"ownership":{"direct":true},"balance_after":26443,"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2186593,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-10","kind":"sale","acquired":false,"shares":991,"price":32.0118,"value":31723.6938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $32.00 to $32.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2186592,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-13T01:30:52.000Z","date":"2022-08-10","kind":"exercise","acquired":true,"shares":991,"price":6.41,"value":6352.31,"ownership":{"direct":true},"balance_after":13784,"source":{"system":"sec-edgar","filing":"0001140361-22-029517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122029517/form4.xml","form_type":"4"}},{"id":2192944,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-06T01:34:01.000Z","date":"2022-08-05","kind":"exercise","acquired":false,"shares":21506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The Reporting Person holds options that give him the right to acquire an aggregate of 2,060,938 shares at exercises prices ranging from $6.41 to $32.45, of which 1,529,478 are currently exercisable, and 531,460 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award."}],"balance_after":56238,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":21506},"source":{"system":"sec-edgar","filing":"0001567619-22-015086","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922015086/doc1.xml","form_type":"4"}},{"id":2192943,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-06T01:34:01.000Z","date":"2022-08-04","kind":"exercise","acquired":false,"shares":20954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":77744,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":20954},"source":{"system":"sec-edgar","filing":"0001567619-22-015086","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922015086/doc1.xml","form_type":"4"}},{"id":2192942,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-06T01:34:01.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":4673,"price":33.0633,"value":154504.8009,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $33.00 to $33.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001567619-22-015086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922015086/doc1.xml","form_type":"4"}},{"id":2192941,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-06T01:34:01.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":16833,"price":32.7665,"value":551558.4945,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $32.00 to $32.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":17466,"source":{"system":"sec-edgar","filing":"0001567619-22-015086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922015086/doc1.xml","form_type":"4"}},{"id":2192940,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-06T01:34:01.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":21506,"price":6.41,"value":137853.46,"ownership":{"direct":true},"balance_after":34299,"source":{"system":"sec-edgar","filing":"0001567619-22-015086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922015086/doc1.xml","form_type":"4"}},{"id":2192939,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-06T01:34:01.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":20954,"price":32.1808,"value":674316.4832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $32.00 to $32.465, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001567619-22-015086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922015086/doc1.xml","form_type":"4"}},{"id":2192938,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-06T01:34:01.000Z","date":"2022-08-04","kind":"exercise","acquired":true,"shares":20954,"price":6.41,"value":134315.14,"ownership":{"direct":true},"balance_after":33747,"source":{"system":"sec-edgar","filing":"0001567619-22-015086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761922015086/doc1.xml","form_type":"4"}},{"id":2199990,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-30T01:30:31.000Z","date":"2022-07-27","kind":"exercise","acquired":false,"shares":376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person holds options that give him the right to acquire an aggregate of 2,103,398 shares at exercises prices ranging from $6.41 to $32.45, of which 1,571,938 are currently exercisable, and 531,460 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award."}],"balance_after":98698,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":376},"source":{"system":"sec-edgar","filing":"0001140361-22-027528","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122027528/form4.xml","form_type":"4"}},{"id":2199989,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-07-30T01:30:31.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":376,"price":32,"value":12032.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001140361-22-027528","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122027528/form4.xml","form_type":"4"}},{"id":2199988,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-07-30T01:30:31.000Z","date":"2022-07-27","kind":"exercise","acquired":true,"shares":376,"price":6.41,"value":2410.16,"ownership":{"direct":true},"balance_after":13169,"source":{"system":"sec-edgar","filing":"0001140361-22-027528","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122027528/form4.xml","form_type":"4"}},{"id":2371470,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-26T02:32:27.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 23, 2023 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":32.45,"expiration_date":"2032-02-23","underlying":"Ordinary Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001140361-22-006900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000114036122006900/form4.xml","form_type":"4"}},{"id":2829038,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-26T22:13:21.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 25, 2020, the reporting person was granted an option to purchase 50,000 ordinary shares. The shares subject to the option vested in full based on the achievement of certain performance criteria."}],"balance_after":50000,"derivative":{"exercise_price":12.15,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-005088","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921005088/doc1.xml","form_type":"4"}},{"id":2829037,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-26T22:13:21.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":22.6,"expiration_date":"2031-02-25","underlying":"Ordinary Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001567619-21-005088","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921005088/doc1.xml","form_type":"4"}},{"id":2853430,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":140601,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 187,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018.  In exchange, the reporting person received a replacement option, for 140,601 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to the option will vest and become exercisable as to 47/48 of the total number of shares subject to the option on the one year anniversary of the date of grant and with respect to 1/48 of the total number of shares subject to the option on February 21, 2022, subject to the reporting person's continued service with the issuer on each such vesting date."}],"balance_after":140601,"derivative":{"exercise_price":22.85,"expiration_date":"2028-02-21","underlying":"Ordinary Shares","underlying_shares":140601},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853429,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":187000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 187,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018.  In exchange, the reporting person received a replacement option, for 140,601 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":33.1,"expiration_date":"2028-02-21","underlying":"Ordinary Shares","underlying_shares":187000},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853428,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 120,000 of the issuer's ordinary shares granted to the reporting person on February 22, 2017.  In exchange, the reporting person received a replacement option, for 62,500 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":62500,"derivative":{"exercise_price":22.85,"expiration_date":"2027-02-22","underlying":"Ordinary Shares","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853427,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 120,000 of the issuer's ordinary shares granted to the reporting person on February 22, 2017.  In exchange, the reporting person received a replacement option, for 62,500 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 22, 2018 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":55,"expiration_date":"2027-02-22","underlying":"Ordinary Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853426,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":16759,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on November 2, 2016.  In exchange, the reporting person received a replacement option, for 16,759 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":16759,"derivative":{"exercise_price":22.85,"expiration_date":"2026-11-02","underlying":"Ordinary Shares","underlying_shares":16759},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853425,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on November 2, 2016.  In exchange, the reporting person received a replacement option, for 16,759 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":45.13,"exercise_date":"2020-09-30","expiration_date":"2026-11-02","underlying":"Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853424,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":25125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 of the issuer's ordinary shares granted to the reporting person on September 1, 2016.  In exchange, the reporting person received a replacement option, for 25,125 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":25125,"derivative":{"exercise_price":22.85,"expiration_date":"2026-09-01","underlying":"Ordinary Shares","underlying_shares":25125},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853423,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 of the issuer's ordinary shares granted to the reporting person on September 1, 2016.  In exchange, the reporting person received a replacement option, for 25,125 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":52.21,"exercise_date":"2020-09-01","expiration_date":"2026-09-01","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853422,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":40625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on February 24, 2016.  In exchange, the reporting person received a replacement option, for 40,625 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":40625,"derivative":{"exercise_price":22.85,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":40625},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853421,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on February 24, 2016.  In exchange, the reporting person received a replacement option, for 40,625 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":34.61,"exercise_date":"2020-02-24","expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853420,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":59090,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on March 11, 2015.  In exchange, the reporting person received a replacement option, for 59,090 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":59090,"derivative":{"exercise_price":22.85,"expiration_date":"2025-03-11","underlying":"Ordinary Shares","underlying_shares":59090},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":2853419,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:41:43.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on March 11, 2015.  In exchange, the reporting person received a replacement option, for 59,090 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":27.81,"exercise_date":"2019-03-11","expiration_date":"2025-03-11","underlying":"Ordinary Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001567619-21-004310","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761921004310/doc1.xml","form_type":"4"}},{"id":3051914,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-19T20:31:05.000Z","date":"2020-08-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects cash exercise of stock option without the disposition of the underlying shares."}],"balance_after":99074,"derivative":{"exercise_price":6.41,"exercise_date":"2017-01-29","expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-20-015757","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761920015757/doc1.xml","form_type":"4"}},{"id":3051913,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2020-08-19T20:31:05.000Z","date":"2020-08-17","kind":"exercise","acquired":true,"shares":10000,"price":6.41,"value":64100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects cash exercise of stock option without the disposition of the underlying shares."}],"balance_after":12793,"source":{"system":"sec-edgar","filing":"0001567619-20-015757","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761920015757/doc1.xml","form_type":"4"}},{"id":3243471,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-27T22:13:47.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":12.15,"expiration_date":"2030-02-25","underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001567619-20-005017","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000156761920005017/doc1.xml","form_type":"4"}},{"id":3622676,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-01T21:16:45.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":245000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":245000,"derivative":{"exercise_price":13.53,"expiration_date":"2029-02-27","underlying":"Ordinary Shares","underlying_shares":245000},"source":{"system":"sec-edgar","filing":"0000899243-19-005428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924319005428/doc4.xml","form_type":"4"}},{"id":3883816,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-25T20:30:25.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":620000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on June 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":620000,"derivative":{"exercise_price":15.04,"expiration_date":"2028-06-21","underlying":"Ordinary Shares","underlying_shares":620000},"source":{"system":"sec-edgar","filing":"0000899243-18-017928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924318017928/doc4.xml","form_type":"4"}},{"id":4036425,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-23T21:08:12.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":187000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":187000,"derivative":{"exercise_price":33.1,"expiration_date":"2028-02-21","underlying":"Ordinary Shares","underlying_shares":187000},"source":{"system":"sec-edgar","filing":"0000899243-18-005304","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924318005304/doc4.xml","form_type":"4"}},{"id":4198961,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-29T21:16:44.000Z","date":"2017-09-28","kind":"exercise","acquired":false,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":109074,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":2800},"source":{"system":"sec-edgar","filing":"0000899243-17-022967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317022967/doc4.xml","form_type":"4"}},{"id":4198960,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-09-29T21:16:44.000Z","date":"2017-09-28","kind":"sale","acquired":false,"shares":2800,"price":70,"value":196000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."}],"balance_after":2793,"source":{"system":"sec-edgar","filing":"0000899243-17-022967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317022967/doc4.xml","form_type":"4"}},{"id":4198959,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-09-29T21:16:44.000Z","date":"2017-09-28","kind":"exercise","acquired":true,"shares":2800,"price":6.41,"value":17948.0,"ownership":{"direct":true},"balance_after":5593,"source":{"system":"sec-edgar","filing":"0000899243-17-022967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317022967/doc4.xml","form_type":"4"}},{"id":4402575,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option\n(right to buy)","published_at":"2017-03-03T21:05:23.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":25163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":111874,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":25163},"source":{"system":"sec-edgar","filing":"0000899243-17-006338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317006338/doc4.xml","form_type":"4"}},{"id":4402574,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-03-03T21:05:23.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":12822,"price":61.2444,"value":785275.6968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $61.00 to $61.66, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2793,"source":{"system":"sec-edgar","filing":"0000899243-17-006338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317006338/doc4.xml","form_type":"4"}},{"id":4402573,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-03-03T21:05:23.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":12341,"price":60.2846,"value":743972.2486,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $60.00 to $60.995, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15615,"source":{"system":"sec-edgar","filing":"0000899243-17-006338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317006338/doc4.xml","form_type":"4"}},{"id":4402572,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-03-03T21:05:23.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":25163,"price":6.41,"value":161294.83,"ownership":{"direct":true},"balance_after":27956,"source":{"system":"sec-edgar","filing":"0000899243-17-006338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317006338/doc4.xml","form_type":"4"}},{"id":4408260,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option\n(right to buy)","published_at":"2017-03-02T21:05:34.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":3796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":137037,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":3796},"source":{"system":"sec-edgar","filing":"0000899243-17-006027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317006027/doc4.xml","form_type":"4"}},{"id":4408259,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-03-02T21:05:34.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":3796,"price":60,"value":227760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."}],"balance_after":2793,"source":{"system":"sec-edgar","filing":"0000899243-17-006027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317006027/doc4.xml","form_type":"4"}},{"id":4408258,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-03-02T21:05:34.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":3796,"price":6.41,"value":24332.36,"ownership":{"direct":true},"balance_after":6589,"source":{"system":"sec-edgar","filing":"0000899243-17-006027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317006027/doc4.xml","form_type":"4"}},{"id":4424033,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-24T21:06:00.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 22, 2018 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":55,"expiration_date":"2027-02-22","underlying":"Ordinary Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-17-005221","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924317005221/doc4.xml","form_type":"4"}},{"id":4560350,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-10T22:11:06.000Z","date":"2016-11-09","kind":"exercise","acquired":false,"shares":8548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":140833,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":8548},"source":{"system":"sec-edgar","filing":"0000899243-16-033196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316033196/doc4.xml","form_type":"4"}},{"id":4560349,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2016-11-10T22:11:06.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":8548,"price":55.3235,"value":472905.278,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $55.00 to $55.90, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2793,"source":{"system":"sec-edgar","filing":"0000899243-16-033196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316033196/doc4.xml","form_type":"4"}},{"id":4560348,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2016-11-10T22:11:06.000Z","date":"2016-11-09","kind":"exercise","acquired":true,"shares":8548,"price":6.41,"value":54792.68,"ownership":{"direct":true},"balance_after":11341,"source":{"system":"sec-edgar","filing":"0000899243-16-033196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316033196/doc4.xml","form_type":"4"}},{"id":4566378,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-04T20:06:49.000Z","date":"2016-11-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on September 30, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":45.13,"expiration_date":"2026-11-02","underlying":"Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-16-032768","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316032768/doc4.xml","form_type":"4"}},{"id":4576024,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-21T21:23:54.000Z","date":"2016-10-21","kind":"exercise","acquired":false,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":149381,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0000899243-16-032172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316032172/doc4.xml","form_type":"4"}},{"id":4576023,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-21T21:23:54.000Z","date":"2016-10-20","kind":"exercise","acquired":false,"shares":14785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":155215,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":14785},"source":{"system":"sec-edgar","filing":"0000899243-16-032172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316032172/doc4.xml","form_type":"4"}},{"id":4576022,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2016-10-21T21:23:54.000Z","date":"2016-10-21","kind":"sale","acquired":false,"shares":5834,"price":55.15,"value":321745.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $55 to $55.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby\nundertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2793,"source":{"system":"sec-edgar","filing":"0000899243-16-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316032172/doc4.xml","form_type":"4"}},{"id":4576021,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2016-10-21T21:23:54.000Z","date":"2016-10-21","kind":"exercise","acquired":true,"shares":5834,"price":6.41,"value":37395.94,"ownership":{"direct":true},"balance_after":8627,"source":{"system":"sec-edgar","filing":"0000899243-16-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316032172/doc4.xml","form_type":"4"}},{"id":4576020,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2016-10-21T21:23:54.000Z","date":"2016-10-20","kind":"sale","acquired":false,"shares":14785,"price":55.08,"value":814357.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $55 to $55.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby\nundertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2793,"source":{"system":"sec-edgar","filing":"0000899243-16-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316032172/doc4.xml","form_type":"4"}},{"id":4576019,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2016-10-21T21:23:54.000Z","date":"2016-10-20","kind":"exercise","acquired":true,"shares":14785,"price":6.41,"value":94771.85,"ownership":{"direct":true},"balance_after":17578,"source":{"system":"sec-edgar","filing":"0000899243-16-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316032172/doc4.xml","form_type":"4"}},{"id":4610577,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":27703,"kind":"person","name":"Kinney Gene G.","position":1,"cik":"0001564380","reported_name":"Kinney Gene G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-06T20:30:32.000Z","date":"2016-09-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on September 1, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":52.21,"expiration_date":"2026-09-01","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-16-028539","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000089924316028539/doc4.xml","form_type":"4"}}]}